作者:
Durga,Borkar [1]
;
Ehsan,Rahimy [2]
;
Mohammed Ali,Khan [3]
;
Allen C,Ho [3]
;
Meghan,Hatfield [4]
;
Thai Hien,Nguyen [4]
;
Daniel,Jones [5]
;
Mitchell S,Fineman [3]
;
Alex,McKeown [6]
;
Theodore,Leng [7]
;
Caroline R,Baumal [8]
;
Nancy,Holekamp [9]
作者单位:
Department of Ophthalmology, Duke University Eye Center, Durham, North Carolina. Electronic address: durga.borkar@duke.edu.
[1]
Palo Alto Medical Foundation, Sutter Health, Palo Alto, California; Department of Ophthamology, Byers Eye Institute at Stanford University School of Medicine, Palo Alto, California.
[2]
Retina Service, Wills Eye Hospital, Philadelphia, Pennsylvania.
[3]
Quantitative Sciences, Verana Health, San Francisco, California.
[4]
Medical Affairs, Apellis Pharmaceuticals, Waltham, Massachusetts.
[5]
Translational Development, Apellis Pharmaceuticals, Waltham, Massachusetts.
[6]
Department of Ophthamology, Byers Eye Institute at Stanford University School of Medicine, Palo Alto, California.
[7]
Medical Affairs, Apellis Pharmaceuticals, Waltham, Massachusetts; Retinal and Macular Disease, New England Eye Center, Boston, Massachusetts.
[8]
Retina Services, Pepose Vision Institute, St Louis, Missouri.
[9]
DOI
10.1016/j.oret.2024.11.013
PMID
39571793
发布时间
2024-12-21